Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…
Davis Polk advised China International Capital Corporation Limited in connection with its placing of 176,000,000 new H shares at a total consideration of approximately HK$2.5 billion …
Davis Polk advised the initial purchasers in connection with a $225 million Regulation S only high-yield offering by China Aoyuan Group Limited of its 7.95% senior notes due 2023.
China…